Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment

Codelivery is a promising strategy to overcome the limitations of single chemotherapeutic agents in cancer treatment. Despite progress, codelivery of two or more different functional drugs to increase anticancer efficiency still remains a challenge. Here, reduction-sensitive lipid–polymer hybrid nan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bo, Lu, Shu-Ting, Zhang, Liu-Jie, Zhuo, Ren-Xi, Xu, Hai-Bo, Huang, Shi-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352248/
https://www.ncbi.nlm.nih.gov/pubmed/28331310
http://dx.doi.org/10.2147/IJN.S131235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352248/
https://www.ncbi.nlm.nih.gov/pubmed/28331310
http://dx.doi.org/10.2147/IJN.S131235

Ejemplares similares